Combination therapy for carbapenem-resistant Gram-negative bacteria
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination therapy for carbapenem-resistant Gram-negative bacteria
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 11, Issue 12, Pages 1333-1353
Publisher
Informa UK Limited
Online
2013-11-06
DOI
10.1586/14787210.2013.845523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unknown
- (2016) INTERNAL MEDICINE JOURNAL
- Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
- (2013) Jae H. Hong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Giancarlo Ceccarelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
- (2013) Helen Giamarellou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam
- (2013) Sutep Jaruratanasirikul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantifying Subpopulation Synergy for Antibiotic Combinations via Mechanism-Based Modeling and a Sequential Dosing Design
- (2013) Cornelia B. Landersdorfer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
- (2013) Haiqing Chu et al. Brazilian Journal of Infectious Diseases
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
- (2013) H. W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)
- (2013) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
- (2013) Y.-T. Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
- (2013) Niteen D. Karnik et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis
- (2013) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
- (2013) Dora E. Wiskirchen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs
- (2013) M. Hagihara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections
- (2013) Emil Lesho et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa
- (2013) D. M. Hermes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Aminoglycoside Antibiotics in the 21st Century
- (2012) Bernd Becker et al. ACS Chemical Biology
- Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
- (2012) Federico Pea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration
- (2012) Matti Karvanen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2012) Zakuan Z. Deris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
- (2012) P. Prasad et al. CLINICAL INFECTIOUS DISEASES
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- ‘Old’ antibiotics for emerging multidrug-resistant bacteria
- (2012) Phillip J. Bergen et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
- (2012) Phillip J. Bergen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Therapeutic options forAcinetobacter baumanniiinfections: an update
- (2012) Jordi Vila et al. EXPERT OPINION ON PHARMACOTHERAPY
- Bloodstream infections caused by carbapenemase-producingKlebsiella pneumoniae: a clinical perspective
- (2012) George L Daikos et al. Expert Review of Anti-Infective Therapy
- Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii
- (2012) M. H. Rigatto et al. INFECTION
- Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin
- (2012) Anucha Apisarnthanarak et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region
- (2012) Pattarachai Kiratisin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
- (2012) A. M. Sandri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases
- (2012) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study
- (2012) N. Markou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
- (2012) Grace C Lee et al. Annals of Clinical Microbiology and Antimicrobials
- Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
- (2011) Phillip J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats
- (2011) Jumana M. Yousef et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline
- (2011) Sujata M. Bhavnani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
- (2011) Ching-Lan Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
- (2011) Maria Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of Aminoglycoside Therapy
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model
- (2011) Phillip J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
- (2011) Michael J. Satlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenems: Past, Present, and Future
- (2011) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients
- (2011) Wang Liang et al. BMC INFECTIOUS DISEASES
- Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case Report
- (2011) A. L. H. Kwa et al. CLINICAL INFECTIOUS DISEASES
- Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)-Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258
- (2011) T. Bogdanovich et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin pharmacokinetics: the fog is lifting
- (2011) W. Couet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fosfomycin: an old—new antibiotic
- (2011) R. Raz CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
- (2011) W Couet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients
- (2011) Jurgen B. Bulitta et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU
- (2011) Wang-Huei Sheng et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005–2009)
- (2011) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment
- (2011) Iain J Abbott et al. Expert Review of Anti-Infective Therapy
- Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy
- (2011) R. Guner et al. INFECTION
- Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials
- (2011) Ronit Marcus et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The revival of fosfomycin
- (2011) Argyris S. Michalopoulos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
- (2011) G. Meletis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
- (2011) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
- (2011) A. C. Gales et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Independent Emergence of Colistin-Resistant Enterobacteriaceae Clinical Isolates without Colistin Treatment : Table 1.
- (2011) Shudan Chen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Metallo-β-lactamases: a last frontier for β-lactams?
- (2011) Giuseppe Cornaglia et al. LANCET INFECTIOUS DISEASES
- Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides
- (2011) Luke F. Chen et al. MEDICAL CLINICS OF NORTH AMERICA
- Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
- (2011) Tze-Peng Lim et al. PLoS One
- Fosfomycin: Efficacy against infections caused by multidrug-resistant bacteria
- (2011) Aurélien Dinh et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli
- (2010) C. Urban et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia
- (2010) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency of Spontaneous Resistance to Fosfomycin Combined with Different Antibiotics in Pseudomonas aeruginosa
- (2010) A. Rodriguez-Rojas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
- (2010) Yun Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
- (2010) M. E. Pachon-Ibanez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression
- (2010) A. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
- (2010) P. J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
- (2010) Diamantis P. Kofteridis et al. CLINICAL INFECTIOUS DISEASES
- Optimizing Aminoglycoside Use
- (2010) William A. Craig CRITICAL CARE CLINICS
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials
- (2010) George Samonis et al. Future Microbiology
- The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes
- (2010) George H. Talbot INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Emerging carbapenemases: a global perspective
- (2010) Timothy R. Walsh INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
- (2010) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic
- (2010) L. S. Elias et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Removal of colistin during intermittent haemodialysis in two critically ill patients
- (2010) S. Marchand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effectiveness and safety of colistin: prospective comparative cohort study
- (2010) Mical Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia
- (2010) C. H. Kvitko et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NDM-1 — A Cause for Worldwide Concern
- (2010) Robert C. Moellering NEW ENGLAND JOURNAL OF MEDICINE
- Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections
- (2010) Alexandro Rodríguez-Rojas et al. PLoS One
- Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa
- (2010) R. Dhar et al. THORAX
- In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differing Effects of Combination Chemotherapy with Meropenem and Tobramycin on Cell Kill and Suppression of Resistance of Wild-Type Pseudomonas aeruginosa PAO1 and Its Isogenic MexAB Efflux Pump-Overexpressed Mutant
- (2009) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?
- (2009) M. Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
- (2009) R. V. Dudhani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
- (2009) I.P. Korbila et al. CLINICAL MICROBIOLOGY AND INFECTION
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
- AmpC -Lactamases
- (2009) G. A. Jacoby CLINICAL MICROBIOLOGY REVIEWS
- Fosfomycin: an old, new friend?
- (2009) M. Popovic et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Multidrug-resistantPseudomonas aeruginosaandAcinetobacter baumannii: resistance mechanisms and implications for therapy
- (2009) Alexandre P Zavascki et al. Expert Review of Anti-Infective Therapy
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore
- (2009) Tze-Peng Lim et al. JOURNAL OF ANTIBIOTICS
- Off-label use of antibiotics in hospitalized patients: focus on tigecycline
- (2009) D. Curcio JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
- (2009) Jason A. Roberts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis
- (2009) B. A. Cunha JOURNAL OF CLINICAL MICROBIOLOGY
- Adjunctive Aerosolized Antibiotics for Treatment of Ventilator-Associated Pneumonia
- (2009) Quinn A Czosnowski et al. PHARMACOTHERAPY
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
- (2008) Alexandre P. Zavascki et al. CLINICAL INFECTIOUS DISEASES
- Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
- (2008) N. Petrosillo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Polymyxins Revisited
- (2008) D. Landman et al. CLINICAL MICROBIOLOGY REVIEWS
- Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
- (2008) M. E. Falagas et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- What is in the pipeline for Gram-negative pathogens?
- (2008) George H Talbot Expert Review of Anti-Infective Therapy
- Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
- (2008) Julia Langgartner et al. INTENSIVE CARE MEDICINE
- Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
- (2008) Joon Young Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
- (2008) M. S. Oliveira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
- (2008) Wing Yau et al. JOURNAL OF INFECTION
- Intravenous colistimethate for multidrug-resistant Gram-negative bacteria
- (2008) Alexandre P Zavascki et al. LANCET INFECTIOUS DISEASES
- Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
- (2007) Andrea L.H. Kwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now